Logo image of WOOF

PETCO HEALTH AND WELLNESS CO (WOOF) Stock Fundamental Analysis

NASDAQ:WOOF - Nasdaq - US71601V1052 - Common Stock - Currency: USD

2.91  -0.08 (-2.68%)

After market: 2.8999 -0.01 (-0.35%)

Fundamental Rating

1

Overall WOOF gets a fundamental rating of 1 out of 10. We evaluated WOOF against 120 industry peers in the Specialty Retail industry. WOOF may be in some trouble as it scores bad on both profitability and health. WOOF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

WOOF had negative earnings in the past year.
In the past year WOOF had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: WOOF reported negative net income in multiple years.
WOOF had a positive operating cash flow in each of the past 5 years.
WOOF Yearly Net Income VS EBIT VS OCF VS FCFWOOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.12%, WOOF is doing worse than 60.68% of the companies in the same industry.
With a Return On Equity value of -9.85%, WOOF perfoms like the industry average, outperforming 41.03% of the companies in the same industry.
Industry RankSector Rank
ROA -2.12%
ROE -9.85%
ROIC N/A
ROA(3y)-6.66%
ROA(5y)-4.39%
ROE(3y)-32.35%
ROE(5y)-23.03%
ROIC(3y)N/A
ROIC(5y)N/A
WOOF Yearly ROA, ROE, ROICWOOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

WOOF's Operating Margin has declined in the last couple of years.
WOOF has a Gross Margin (37.53%) which is comparable to the rest of the industry.
WOOF's Gross Margin has declined in the last couple of years.
WOOF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.53%
OM growth 3Y-43.66%
OM growth 5Y-27.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-2.8%
WOOF Yearly Profit, Operating, Gross MarginsWOOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

WOOF does not have a ROIC to compare to the WACC, probably because it is not profitable.
WOOF has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, WOOF has more shares outstanding
WOOF has a worse debt/assets ratio than last year.
WOOF Yearly Shares OutstandingWOOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
WOOF Yearly Total Debt VS Total AssetsWOOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

WOOF has an Altman-Z score of 0.98. This is a bad value and indicates that WOOF is not financially healthy and even has some risk of bankruptcy.
WOOF's Altman-Z score of 0.98 is on the low side compared to the rest of the industry. WOOF is outperformed by 76.07% of its industry peers.
A Debt/Equity ratio of 1.40 is on the high side and indicates that WOOF has dependencies on debt financing.
With a Debt to Equity ratio value of 1.40, WOOF is not doing good in the industry: 64.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Altman-Z 0.98
ROIC/WACCN/A
WACC9.55%
WOOF Yearly LT Debt VS Equity VS FCFWOOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

WOOF has a Current Ratio of 0.84. This is a bad value and indicates that WOOF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.84, WOOF is not doing good in the industry: 86.32% of the companies in the same industry are doing better.
WOOF has a Quick Ratio of 0.84. This is a bad value and indicates that WOOF is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of WOOF (0.22) is worse than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.22
WOOF Yearly Current Assets VS Current LiabilitesWOOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for WOOF have decreased strongly by -120.00% in the last year.
Looking at the last year, WOOF shows a small growth in Revenue. The Revenue has grown by 1.30% in the last year.
Measured over the past years, WOOF shows a small growth in Revenue. The Revenue has been growing by 7.33% on average per year.
EPS 1Y (TTM)-120%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y8.33%
Revenue growth 5Y7.33%
Sales Q2Q%1.16%

3.2 Future

Based on estimates for the next years, WOOF will show a very strong growth in Earnings Per Share. The EPS will grow by 39.73% on average per year.
Based on estimates for the next years, WOOF will show a small growth in Revenue. The Revenue will grow by 1.40% on average per year.
EPS Next Y-178.2%
EPS Next 2Y-18.98%
EPS Next 3Y23.32%
EPS Next 5Y39.73%
Revenue Next Year-0.92%
Revenue Next 2Y0.75%
Revenue Next 3Y1.21%
Revenue Next 5Y1.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WOOF Yearly Revenue VS EstimatesWOOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
WOOF Yearly EPS VS EstimatesWOOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WOOF. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 49.26, which means the current valuation is very expensive for WOOF.
Based on the Price/Forward Earnings ratio, WOOF is valued a bit more expensive than the industry average as 60.68% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of WOOF to the average of the S&P500 Index (22.68), we can say WOOF is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 49.26
WOOF Price Earnings VS Forward Price EarningsWOOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

WOOF's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.55
WOOF Per share dataWOOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as WOOF's earnings are expected to grow with 23.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.98%
EPS Next 3Y23.32%

More info and screens

0

5. Dividend

5.1 Amount

WOOF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PETCO HEALTH AND WELLNESS CO

NASDAQ:WOOF (2/21/2025, 8:00:02 PM)

After market: 2.8999 -0.01 (-0.35%)

2.91

-0.08 (-2.68%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-05 2024-12-05/amc
Earnings (Next)05-20 2025-05-20/bmo
Inst Owners69.08%
Inst Owner Change-30.63%
Ins Owners4.23%
Ins Owner Change2.75%
Market Cap912.14M
Analysts71.11
Price Target4.96 (70.45%)
Short Float %36.54%
Short Ratio6.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.44%
Min EPS beat(2)15.3%
Max EPS beat(2)47.57%
EPS beat(4)4
Avg EPS beat(4)33.23%
Min EPS beat(4)15.3%
Max EPS beat(4)47.57%
EPS beat(8)6
Avg EPS beat(8)-24.32%
EPS beat(12)9
Avg EPS beat(12)-16.01%
EPS beat(16)13
Avg EPS beat(16)-1.62%
Revenue beat(2)0
Avg Revenue beat(2)-1.64%
Min Revenue beat(2)-2.01%
Max Revenue beat(2)-1.28%
Revenue beat(4)1
Avg Revenue beat(4)-0.69%
Min Revenue beat(4)-2.01%
Max Revenue beat(4)1.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.1%
Revenue beat(12)2
Avg Revenue beat(12)-1.16%
Revenue beat(16)6
Avg Revenue beat(16)0.08%
PT rev (1m)-1.58%
PT rev (3m)24.88%
EPS NQ rev (1m)-52.23%
EPS NQ rev (3m)-63.63%
EPS NY rev (1m)-3.98%
EPS NY rev (3m)-10.05%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-1.18%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 49.26
P/S 0.15
P/FCF N/A
P/OCF 7.09
P/B 0.81
P/tB N/A
EV/EBITDA 12.55
EPS(TTM)-0.06
EYN/A
EPS(NY)0.06
Fwd EY2.03%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.41
OCFY14.11%
SpS19.9
BVpS3.58
TBVpS-2.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.12%
ROE -9.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.53%
FCFM N/A
ROA(3y)-6.66%
ROA(5y)-4.39%
ROE(3y)-32.35%
ROE(5y)-23.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.4%
ROCE(5y)3.28%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.66%
OM growth 5Y-27.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-2.8%
F-Score4
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF N/A
Debt/EBITDA 8.24
Cap/Depr 69.5%
Cap/Sales 2.25%
Interest Coverage N/A
Cash Conversion 67.23%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.22
Altman-Z 0.98
F-Score4
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)131.5%
Cap/Depr(5y)115.3%
Cap/Sales(3y)4.11%
Cap/Sales(5y)3.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-120%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y-178.2%
EPS Next 2Y-18.98%
EPS Next 3Y23.32%
EPS Next 5Y39.73%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y8.33%
Revenue growth 5Y7.33%
Sales Q2Q%1.16%
Revenue Next Year-0.92%
Revenue Next 2Y0.75%
Revenue Next 3Y1.21%
Revenue Next 5Y1.4%
EBIT growth 1Y-108.5%
EBIT growth 3Y-38.96%
EBIT growth 5Y-22.28%
EBIT Next Year111.87%
EBIT Next 3Y37.29%
EBIT Next 5Y25%
FCF growth 1Y-50.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.92%
OCF growth 3Y-7.05%
OCF growth 5Y1.2%